Jpmorgan Chase & CO Medicinova Inc Call Options Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding MNOV
# of Institutions
33Shares Held
4.69MCall Options Held
7.2KPut Options Held
3.8K-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.86 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.17 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA459KShares$770,7250.0% of portfolio
-
Citigroup Inc448KShares$752,5670.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $82.4M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...